Insider · CIK 0001269131
Glenn Steele Jr Md Phd
director
Files at PTCT (PTC THERAPEUTICS, INC.). First filing Oct 2, 2026, latest Oct 2, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $782k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PTCT: PTC THERAPEUTICS, INC.
PTCTOct 9, 2026 · close 64.70
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | PTC THERAPEUTICS, INC. | $782k 12,000 shares | -35% | +6% from low-28% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Common Stock10b5-1 | +12,000 | $11.23 | $135k | 34,500 | 10 d ago |
| Sep 30, 2026 | PTCT PTC THERAPEUTICS, INC. | SOpen-market sale Common Stock10b5-1 | -12,000 | $65.16 | $782k | 22,500 | 10 d ago |
| Sep 30, 2026 | PTCT PTC THERAPEUTICS, INC. | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -12,000 | $0.00 | $0 | 0 | 10 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.